Status:
UNKNOWN
New Treatment in Erectile Dysfunction Patients.
Lead Sponsor:
Sohag University
Conditions:
Erectile Dysfunction
Eligibility:
MALE
Phase:
NA
Brief Summary
Erectile dysfunction patients who are non responder to sildenafil will be treated with hyperbaric oxygen therapy with 100% concentration and at 2 ATM for 30 consecutive sessions each one 90 minutes an...
Detailed Description
This study is double blinded randomized controlled clinical trial that includes organic ED patients who attend to the Andrology out patient clinics, Department of Dermatology, Venerology and Andrology...
Eligibility Criteria
Inclusion
- Patients with regular sexual relationship in the last 6 months
- having organic ED and
- non responder to Sildenafil were included in our study.
Exclusion
- Hypogonadism,
- History of Pelvic trauma, surgery or disease,
- Receiving treatment in the last 3 months,
- History of premature ejaculation,
- History of spinal cord or brain disease,
- History of drug abuse,
- Patients without a regular sexual partner,
- Patients with advanced kidney disease (creatinine\>1.3 mg\\dl) or liver disease,
- History of psychiatric diseases,
- HBOT exclusion as open pneumo-thorax, chest disease, sezure and congestive heart failure.
Key Trial Info
Start Date :
January 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 29 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05439486
Start Date
January 29 2022
End Date
October 29 2022
Last Update
June 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine sohag university
Sohag, Egypt